Methylomic biomarkers of lithium response in bipolar disorder: a clinical utility study

BACKGROUND: Response to lithium (Li) is highly variable in bipolar disorders (BD). Despite decades of research, no clinical predictor(s) of response to Li prophylaxis have been consistently identified. Recently, we developed epigenetic Methylation Specific High-Resolution Melting (MS-HRM) assays abl...

Descripción completa

Detalles Bibliográficos
Autores principales: Marie-Claire, C., Courtin, C., Bellivier, F., Gard, S., Leboyer, M., Scott, J., Etain, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148930/
https://www.ncbi.nlm.nih.gov/pubmed/37119343
http://dx.doi.org/10.1186/s40345-023-00296-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148930/
https://www.ncbi.nlm.nih.gov/pubmed/37119343
http://dx.doi.org/10.1186/s40345-023-00296-6

Ejemplares similares